<DOC>
	<DOC>NCT01712438</DOC>
	<brief_summary>Investigate the inhibitor development rate of Human cl rhFVIII in previously untreated patients with severe Hemophilia A.</brief_summary>
	<brief_title>Human-cl-rhFVIII in Previously Untreated Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<criteria>Male patients Severe Hemophilia A (FVIII:C &lt;1%) No previous treatment with with FVIII concentrates or other blood prodcuts containing FVIII Diagnosis with a coagulation disorder other than Hemophilia A Severe liver or kidney disease Concomitant treatment with any systemic immunosuppressive drug</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Previously untreated patients</keyword>
</DOC>